Mono[6-deoxy-6-(l-tyrosylamino)]-β-cyclodextrin (2) was prepared from N-(benzylcarbonyl)-l-tyrosine dicyclohexylamine salt (Z-Tyr DCHA salt) and mono(6-amino-6-deoxy)-β-cyclodextrin. 2 includes N-dansylphenylalanine enantioselectively (KL/KD = 2.13). From an NMR study, it was suggested that the hydroxyphenyl group attached to 2 was located at the outside of the cavity and that 2 had an expanded and distorted cavity enclosed by the hydroxyphenyl moiety and the parent cyclodextrin wall.
No takes yet. Share an insight, caveat, or question.
Keiko Takahashi (1993) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: